Skip to Content
Merck
CN
  • Substrate stiffness induces nuclear localization of myosin regulatory light chain to suppress apoptosis.

Substrate stiffness induces nuclear localization of myosin regulatory light chain to suppress apoptosis.

FEBS letters (2023-02-02)
Katsuya Onishi, Seiichiro Ishihara, Masayuki Takahashi, Akihiro Sakai, Atsushi Enomoto, Kentaro Suzuki, Hisashi Haga
ABSTRACT

Stiffness of the extracellular matrix regulates various biological responses, but the response mechanisms are poorly understood. Here, we found that the nuclear diphosphorylated myosin regulatory light chain (2P-MRLC) is a critical mechanomediator that suppresses apoptosis in response to substrate stiffness. Stiff substrates promoted the nuclear localization of 2P-MRLC. Zipper-interacting protein kinase [ZIPK; also known as death-associated protein kinase 3 (DAPK3)], a kinase for MRLC, was localized in the nucleus in response to stiff substrates and promoted the nuclear localization of 2P-MRLC. Moreover, actin fiber formation induced by substrate stiffness promoted the nuclear localization of 2P-MRLC via ZIPK. 2P-MRLC in response to substrate stiffness suppressed the expression of MAF bZIP transcription factor B (MafB) and repressed apoptosis. These findings reveal a newly identified role of MRLC in mechanotransduction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Jasplakinolide, ≥97% (HPLC)
Sigma-Aldrich
Y-27632 dihydrochloride, ≥98% (HPLC)
Sigma-Aldrich
Monoclonal Anti-Collagen, Type I antibody produced in mouse, clone COL-1, ascites fluid
Sigma-Aldrich
Latrunculin A, from sea sponge, ≥85% (HPLC), waxy solid
Sigma-Aldrich
ML-7, powder
Sigma-Aldrich
Monoclonal Anti-α-Tubulin antibody produced in mouse, clone DM1A, ascites fluid
Sigma-Aldrich
DAPK Inhibitor, The DAPK Inhibitor, also referenced under CAS 315694-89-4, controls the biological activity of DAPK.